Retina World Congress is a non-profit organization dedicated to uniting international professionals to foster dialogue and to generate consensus about retinal diseases, emerging technologies and treatments, best practices and clinical research. Our biennial meeting is our main initiative and has brought together 150 faculty and 1,000 attendees from 32 U.S. states, 74 countries and 40 retina societies from around the globe. We unite again in 2019 to share research, innovations and ideas with a growing audience... and we want you to be a part of it!

This is an extraordinary program created by and for retina specialists

Join us for an innovative experience in education and networking

  • In-depth Education - No other meeting offers such extensive surgical and medical updates for both common and complicated retinal issues that will enhance your expertise across every single area of practice.
  • Advances in Imaging - Gain a new perspective on important innovations in imaging, technology, instruments and devices.
  • Pros vs. Cons - Join interactive discussions surrounding controversies and debates offering a comprehensive perspective from all sides.
  • Science Explained - Receive insight from researchers into case studies, clinical trials and late breaking data, so you can learn, understand and apply the data presented.
  • Peer Research - Exchange ideas with colleagues after viewing video displays and hearing unique presentations given by abstract winners across various topics (submit your own abstract by January 11)
  • Networking Time - Mingle with colleagues and faculty during the welcome reception and other interactive sessions scheduled throughout the long weekend.
  • Earn CME - The program has been approved for 25 AMA PRA Category 1 Credit(s)™.


  • Macular Surgery
  • Medical Retina: Retina Vein Occlusion
  • Trauma and Proliferative Vitreoretinopathy Surgery
  • Surgical Technology
  • Retinal Detachment Surgery
  • Imaging
  • Age-related Macular Degeneration
  • Diabetic Vitrectomy
  • Ocular Oncology
  • Pediatrics, Pediatric Surgery and Gene Therapy
  • Controversies and Debates
  • Medical Retina: Diabetic Macular Edema and Diabetic Retinopathy
  • Uveitis
  • First-time Presentations of Clinical Trials and Late Breakers
This continuing medical education activity is provided by
Meeting organized by
Official Media Partner

Retina World Congress 2019 is supported, in part, by independent educational grants from AbbVie, Inc.; Allergan, Inc.; Carl Zeiss Meditec, Inc.; Genentech, Inc.; Mallinckrodt Pharmaceuticals, Inc.; Novartis Pharmaceuticals Corporation; and Regeneron Pharmaceuticals, Inc.

Retina World Congress 2019 is sponsored by Alcon; Allergan; Genentech; Novartis Pharmaceuticals; Regeneron; Regenxbio; and Santen.